Stock Detail
KING PHARMACEUTICALS INC
Drug Manufacturers Other
KG @ Yahoo Finance | KG Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $14.24 | $14.24 | $0.00 | 0.00% | 0.00 | $14.24 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $0.00 | $0.00 | 0 | 3.56B | 3.09M | 41.88 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 23.73 | 18.98 | 9.49 | 4.74 | -4.75 |
Stock Profile
King Pharmaceuticals, Inc. engages in the development, manufacture, marketing, and sale of branded prescription pharmaceutical products. It offers various branded prescription products over seven therapeutic areas, including cardiovascular, endocrinology, neuroscience, critical care, anti-infective, respiratory, and other. The company also develops, manufactures, and sells auto-injectors for the self-administration of injectable drugs. In addition, King Pharmaceuticals provides contract pharmaceutical manufacturing services to third-party pharmaceutical and biotechnology companies, as well as transfers company's manufacturing and marketing rights to third parties for licensing fees or royalty payments. The company distributes its branded pharmaceutical products primarily through wholesale pharmaceutical distributors and pharmacies to general/family practitioners, internal medicine physicians, cardiologists, endocrinologists, psychiatrists, neurologists, pain specialists, sleep specialists, and hospitals across the United States and in Puerto Rico. King Pharmaceuticals has a strategic collaboration relating to Intal (cromolyn sodium) and Tilade (nedocromil sodium), which includes the development of a new formulation of Intal utilizing hydrofluoroalkane, an environmentally friendly propellant; and with Pain Therapeutics, Inc. to develop and commercialize Remoxy and other abuse-resistant opioid painkillers. King Pharmaceuticals was incorporated in 1993 and is headquartered in Bristol, Tennessee.